NICE moves fourth-line isatuximab into routine myeloma care, with SACT data shaping the comparator story. https://www.mattheneus.com/editorial/nice-ta1194-isatuximab-fourth-line-myeloma-sact-comparator-2026-09-24 #HTA #HealthEconomics #RWE

Germany and Switzerland place cybersecurity responsibility at different points in digital-health reimbursement. https://www.mattheneus.com/editorial/digital-health-cybersecurity-reimbursement-responsibility-germany-switzerland-2026-10-01 #HTA #HealthEconomics #RegulatoryAffairs

Universal malaria testing could save the US blood supply $13.6M in year one. https://www.mattheneus.com/editorial/universal-malaria-nat-screening-us-blood-supply-budget-impact-2026-10-01 #HTA #HealthEconomics #RWE

Anchored MAIC connects tralokinumab and dupilumab evidence in hand atopic dermatitis. #HTA #MAIC #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/pubmed-tralokinumab-dupilumab-hand-atopic-dermatitis-anchored-maic-2026-10-02

A Saudi model puts pembrolizumab for cervical cancer near the cost-effectiveness threshold, sharpening the local value question. https://www.mattheneus.com/editorial/pubmed-pembrolizumab-cervical-cancer-saudi-cost-effectiveness-keynote-a18-2026-10-02 #HTA #HealthEconomics

Disability equity claims need subgroup cost-effectiveness evidence. Five scenarios show why the details matter. https://www.mattheneus.com/editorial/qaly-disability-subgroup-cost-effectiveness-equity-file-2026-09-28 #HTA #HealthEconomics #EvidenceSynthesis

For the UCL Bloomsbury and East London Doctoral programmes, @lshtm.bsky.social offers #PhD studentships in these pathways

💴 Health & Wellbeing (with #HealthEconomics & social science approaches)
👥 Population & Health
📈 Quantitative Social Science

Find out more 🔽
www.lshtm.ac.uk/study/fees-a...

Sweden’s Alhemo decision shows how HTA can reconcile a difficult bleeding endpoint with cost evidence. https://www.mattheneus.com/editorial/tlv-alhemo-concizumab-haemophilia-b-explorer8-cost-comparison-2026-10-02 #HTA #HealthEconomics #Pharma

Still working on your proposal for the 22nd EuroQol Joint Call for Proposals?

Remember, you've got until 25 October at 23:59 CET to submit it 🔔

Supporting high-quality research aligned with EuroQol's aims.

Full RFP: https://bit.ly/46w7SBf

#HealthEconomics #ResearchFunding

Fourteen social-science approaches expand how HTA teams assess uncertainty and support implementation. https://www.mattheneus.com/editorial/social-science-uncertainty-method-selection-hta-policy-implementation-2026-10-02 #HTA #EvidenceSynthesis #HealthEconomics

AI in older-adult care needs measured technology costs before its value case can be trusted. #HTA #HealthEconomics #RWE https://www.mattheneus.com/editorial/ai-older-adult-care-economic-evaluation-cost-validation-gaps-2026-10-01

📣 Upcoming Event | Mental Health Economics: Past, Present and Future

🗓️ October 6 | 1:00–2:30 pm AEDT
💻 Online | 60-minute panel + 30-minute Q&A

🔗 Register here: forms.gle/D4GicTDyozTk...

#MentalHealthEconomics #HealthEconomics #MentalHealth #HealthPolicy #IHEA #AHES

A new tutorial brings model-form uncertainty into observational cost-effectiveness analysis with nonparametric regression. https://www.mattheneus.com/editorial/nonparametric-regression-observational-cost-effectiveness-model-form-2026-10-01 #HTA #RWE #HealthEconomics

Sweden raised Rectogesic’s reimbursed price by 60.6% to protect supply continuity. https://www.mattheneus.com/editorial/tlv-rectogesic-price-increase-supply-continuity-gross-margin-2026-10-01 #HTA #Pharma #HealthEconomics

Save the date - bookings for online health economics short courses go live midday 7 October #healtheconomics

AOTMiT rejected Wegovy reimbursement despite cost-utility results below Poland's statutory threshold, citing a programme population mismatch. #HTA #HealthEconomics https://www.mattheneus.com/editorial/aotmit-wegovy-obesity-programme-population-mismatch-budget-rejection-2026-10-01

Economics of Population Health (EPH) Research Centre, formerly HERC, Health economics related DPhil projects now open for applications on website for October 2027 entry - closing date: 1 December 2026 #healtheconomics

Metabologia wants your research papers on the #metabolic aspects of #diabetes, #obesity #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology – submit now! metabologia.org #EASD2026

I-CEPS 2027 conference #healtheconomics

Reminder: Winter HESG 2027 – Abstract Submission Closing 05/10/26 at 5pm UK time #healtheconomics